Regulation of the mevalonate pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The mevalonate pathway produces isoprenoids that are vital for diverse cellular functions, ranging from cholesterol synthesis to growth control. Several mechanisms for feedback regulation of low-density-lipoprotein receptors and of two enzymes involved in mevalonate biosynthesis ensure the production of sufficient mevalonate for several end-products. Manipulation of this regulatory system could be useful in treating certain forms of cancer as well as heart disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conversion of acetyl-coenzyme A (CoA) to farnesyl diphosphate (FPP) is commonly referred to as the isoprenoid pathway, in which P-hydroxy-P-methylglutaryl(HMG)-CoA reductase is the major site of regulation [5].”
In the citing paper
“Since HMGCR encodes the rate-limiting enzyme of the cholesterol biosynthesis pathway and is tightly regulated at the level of gene transcription by sterol response element binding factor 2 (SREBF2) in response to changes in intracellular sterol content10, we identified genes whose statin-induced expression level changes were most highly correlated with statin-induced changes in HMGCR.”
From Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) · cites this paper as [10]
In the citing paper
“The expression of liver LDL receptor (LDLR) regulates human plasma LDL-cholesterol (LDL-C) homeostasis”
From A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression (2014) · cites this paper as [3]
In the citing paper
“The liver is the organ responsible for removing >70% to 80% of LDL-c from circulation via LDL receptor (LDLR)–mediated endocytosis.”
In the citing paper
“Therefore, the amount of LDLR expressed on the surface of hepatocytes is a major determinant of LDL-c circulating levels.”
Citations
Cites
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citationThe Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
Brown, M. S., & Goldstein, J. L. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42221-7 · Cited by 1,198
Self-citationPromoter-specific activation of RNA polymerase II transcription by Sp1
Kadonaga, J. T., Jones, K. A., & Tjian, R. (1986) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(86)90226-4 · Cited by 1,012
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856
Regulation of HMG-CoA Reductase
RODWELL, V. W., NORDSTROM, J. L., & MITSCHELEN, J. J. (1976) · Advances in Lipid Research · doi:10.1016/b978-0-12-024914-5.50008-5 · Cited by 746
Santoro, C., Mermod, N., Andrews, P. C., & Tjian, R. (1988) · Nature · doi:10.1038/334218a0 · Cited by 715
Segev, N., Mulholland, J., & Botstein, D. (1988) · Cell · doi:10.1016/0092-8674(88)90433-3 · Cited by 689
A family of receptors coupled to guanine nucleotide regulatory proteins
Dohlman, H. G., Caron, M. G., & Lefkowitz, R. J. (1987) · Biochemistry · doi:10.1021/bi00384a001 · Cited by 631
Research works printed but not linked: 3
- Smith, J. R., Osborne, T. F., Goldstein, J. L. & Brown, M. S. J. biol. Chem. (in the press).
- Kamiya, Y., Sakurai, A., Tamura, S. & Takahashi, N. Agric. Biol. Chem. 43, 1049–1053 (1979).
- Gibbs, J. B. & Marshall, M. S. Micro. Rev. 53, 171–185 (1989). · doi:10.1128/mr.53.2.171-185.1989 · Paper page
Cited by
Items 401–500 of 1,062
The Genomes of Three Uneven Siblings: Footprints of the Lifestyles of Three Trichoderma Species
Schmoll, M., Dattenböck, C., Carreras-Villaseñor, N., Mendoza-Mendoza, A., Tisch, D., Alemán, M. I., Baker, S. E., Brown, C., Cervantes-Badillo, M. G., Cetz-Chel, J., et al. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-15 · Cited by 192
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
Bahrami, A., Parsamanesh, N., Atkin, S. L., Banach, M., & Sahebkar, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.014 · Cited by 188
Carroll, R. G., Zasłona, Z., Galván-Peña, S., Koppe, E. L., Sévin, D. C., Angiari, S., Triantafilou, M., Triantafilou, K., Modis, L. K., & O’Neill, L. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001921 · Cited by 189
“The synthesis of cholesterol in cells is a complex pathway that uses acetyl-CoA to produce the 27-carbon structure of cholesterol (12).”
BackgroundDisorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes
Herman, G. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg072 · Cited by 190
Kinjoh, T., Kaneko, Y., Itoyama, K., Mita, K., Hiruma, K., & Shinoda, T. (2007) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2007.03.008 · Cited by 189
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
Beffert, U. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00008-3 · Cited by 189
Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease
Tousoulis, D., Psarros, C., Demosthenous, M., Patel, R., Antoniades, C., & Stefanadis, C. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.054 · Cited by 187
“By inhibiting mevalonate synthesis, statins also prevent the synthesis of other important isoprenoid intermediates of the cholesterol biosynthetic pathway, such as farnesylpyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) (33).”
BackgroundStatins and cancer: Current and future prospects
Osmak, M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.011 · Cited by 189
“The end products of the mevalonate pathway include sterol isoprenoids, such as cholesterol, and nonsterol isoprenoids, such as dolichol, heme-A, isopentenyl tRNA and ubiquinone [1,2] (Fig.”
BackgroundKusama, T., Mukai, M., Iwasaki, T., Tatsuta, M., Matsumoto, Y., Akedo, H., & Nakamura, H. (2001) · PubMed · Cited by 210
Hernández-Perera, O., Pérez-Sala, D., Soria, E., & Lamas, S. (2000) · Circulation Research · doi:10.1161/01.res.87.7.616 · Cited by 188
HMG-CoA reductase guides migrating primordial germ cells
Van Doren, M., Broihier, H. T., Moore, L. A., & Lehmann, R. (1998) · Nature · doi:10.1038/24871 · Cited by 190
“gif" NDATA ITEM> ]> The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase is best known for catalysing a rate-limiting step in cholesterol biosynthesis, but it also participates in the production of a wide variety of other compound”
BackgroundDiOC6 staining reveals organelle structure and dynamics in living yeast cells
Koning, A. J., Lum, P. Y., Williams, J. M., & Wright, R. (1993) · Cell Motility · doi:10.1002/cm.970250202 · Cited by 188
Crowell, P. L., Ren, Z., Lin, S., Vedejs, E., & Gould, M. N. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90341-7 · Cited by 184
Rogers, M. J., Mönkkönen, J., & Munoz, M. A. (2020) · Bone · doi:10.1016/j.bone.2020.115493 · Cited by 178
Pleiotropic effects of HMG-CoA reductase inhibitors
Werner, N., Nickenig, G., & Laufs, U. (2002) · Basic Research in Cardiology · doi:10.1007/s003950200000 · Cited by 185
Roitelman, J., Olender, E., Bar-Nun, S., Dunn, W., & Simoni, R. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.5.959 · Cited by 186
An allosteric mechanism for potent inhibition of human ATP-citrate lyase
Wei, J., Leit, S., Kuai, J., Therrien, E., Rafi, S., Harwood, H. J., DeLaBarre, B., & Tong, L. (2019) · Nature · doi:10.1038/s41586-019-1094-6 · Cited by 176
Liu, Y., Hultén, L. M., & Wiklund, O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.317 · Cited by 187
DAWSON, M. J., FARTHING, J. E., MARSHALL, P. S., MIDDLETON, R. F., O''NEILL, M. J., SHUTTLEWORTH, A., STYLLI, C., TAIT, R. M., TAYLOR, P. M., WILDMAN, H. G., et al. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.639 · Cited by 183
The gamma subunit of transducin is farnesylated.
Lai, R. K., Perez-Sala, D., Cañada, F. J., & Rando, R. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7673 · Cited by 187
Regulation of cholesterol movement to mitochondrial cytochrome P450scc in steroid hormone synthesis
Jefcoate, C. R., McNamara, B. C., Artemenko, I., & Yamazaki, T. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90305-3 · Cited by 187
Kawakami, T., Kawcak, T., Li, Y.-J., Zhang, W., Hu, Y., & Chuang, P.-T. (2002) · Development · doi:10.1242/dev.00178 · Cited by 183
“…(Goodrich et al., 1996); the sterol regulatory element-binding protein [SREBP]-cleavage activation protein (SCAP) (Brown and Goldstein, 1999; Goldstein and Brown, 1990); NPC1, a protein affected in the lipid storage disorder Niemann-Pick disease type C1 (Carstea et al., 1997; Loftus et al.,…”
BackgroundAgarwal, B., Rao, C. V., Bhendwal, S., Ramey, W. R., Shirin, H., Reddy, B. S., & Holt, P. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70342-2 · Cited by 185
Oxysterols, cholesterol homeostasis, and Alzheimer disease
Vaya, J., & Schipper, H. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04689.x · Cited by 183
Hsieh, M.-H., & Goodman, H. M. (2005) · Plant Physiology · doi:10.1104/pp.104.058735 · Cited by 183
“The MVA pathway in animal cells is regulated at multiple levels, including transcriptional, posttranscriptional, and a complex feedback regulatory system (Goldstein and Brown, 1990).”
Backgrounddi Meo, N. A., Lasorsa, F., Rutigliano, M., Loizzo, D., Ferro, M., Stella, A., Bizzoca, C., Vincenti, L., Pandolfo, S. D., Autorino, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214360 · Cited by 178
Taste receptor cells arise from local epithelium, not neurogenic ectoderm.
Stone, L. M., Finger, T. E., Tam, P. P., & Tan, S. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1916 · Cited by 181
Chen, P.-Y., Sun, J.-S., Tsuang, Y.-H., Chen, M.-H., Weng, P.-W., & Lin, F.-H. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.03.004 · Cited by 180
“Statins block cholesterol biosynthesis by competitively inhibiting the rate-limiting enzyme 3-hydroxy-3-methylglutaryl-CoA reductase, which converts 3-hydroxy-3-methylglutaryl-CoA to mevalonate [25].”
BackgroundStatins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180
Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 178
“7D; no change for PBS vs. ATþMV, P¼ 0.08; 37% increase for PBS vs. GGPP, P < 0.03).”
InfluentialMoreau, M., Brocheriou, I., Petit, L., Ninio, E., Chapman, M. J., & Rouis, M. (1999) · Circulation · doi:10.1161/01.cir.99.3.420 · Cited by 180
Grand, R. J. A., & Owen, D. (1991) · Biochemical Journal · doi:10.1042/bj2790609 · Cited by 181
Chen, Y., & Hughes-Fulford, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<41::aid-ijc1009>3.0.co;2-2 · Cited by 179
Shimada, H., Kondo, K., Fraser, P. D., Miura, Y., Saito, T., & Misawa, N. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.7.2676-2680.1998 · Cited by 177
“Previous studies have indicated that HMG-CoA reductase is a key enzyme involved in ergosterol biosynthesis in yeast (5, 6) (Fig.”
BackgroundWang, H., Lynch, J. R., Song, P., Yang, H.-J., Yates, R. B., Mace, B., Warner, D. S., Guyton, J. R., & Laskowitz, D. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.031 · Cited by 183
SPAMPANATO, C., DE MARIA, S., SARNATARO, M., GIORDANO, E., ZANFARDINO, M., BAIANO, S., CARTENÌ, M., & MORELLI, F. (2012) · International Journal of Oncology · doi:10.3892/ijo.2011.1273 · Cited by 179
“CoA (HMG-CoA) reductase, which catalyzes the conversion of HMG-CoA to mevalonate (2).”
HDL and LDL: Potential New Players in Breast Cancer Development
Cedó, L., Reddy, S. T., Mato, E., Blanco-Vaca, F., & Escolà-Gil, J. C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060853 · Cited by 172
“Statins are inhibitors of the enzyme hydroxy-methyl-glutaryl-coenzyme A reductase (HMGCR), which catalyzes the conversion of HMG-CoA to mevalonate, the rate-limiting step of cholesterol synthesis [105].”
BackgroundCybulsky, M. I., Fries, J. W., Williams, A. J., Sultan, P., Eddy, R., Byers, M., Shows, T., Gimbrone, M. A., & Collins, T. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7859 · Cited by 184
Laaksonen, R., Jokelainen, K., Sahi, T., Tikkanen, M. J., & Himberg, J.-J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90266-x · Cited by 177
Synthetic Biology and Metabolic Engineering Approaches To Produce Biofuels
Rabinovitch-Deere, C. A., Oliver, J. W. K., Rodriguez, G. M., & Atsumi, S. (2013) · Chemical Reviews · doi:10.1021/cr300361t · Cited by 174
Fukushima, M., Ohashi, T., Fujiwara, Y., Sonoyama, K., & Nakano, M. (2001) · Experimental Biology and Medicine · doi:10.1177/153537020222600808 · Cited by 177
“The ratelimiting enzyme in endogenous sterol biosynthesis is 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase, which catalyzes the synthesis of mevalonate (6).”
BackgroundIdentification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
Otte, K., Kranz, H., Kober, I., Thompson, P., Hoefer, M., Haubold, B., Remmel, B., Voss, H., Kaiser, C., Albers, M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.864-872.2003 · Cited by 176
“Deregulation of this pathway leads to accumulation of excess cholesterol and can result in diseases such as atherosclerosis and gallstone formation (10).”
BackgroundTrapecar, M., Wogram, E., Svoboda, D., Communal, C., Omer, A., Lungjangwa, T., Sphabmixay, P., Velazquez, J., Schneider, K., Wright, C. W., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd1707 · Cited by 176
Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth
Ghosh-Choudhury, N., Mandal, C. C., Ghosh-Choudhury, N., & Ghosh Choudhury, G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.010 · Cited by 177
Veillard, N. R., Braunersreuther, V., Arnaud, C., Burger, F., Pelli, G., Steffens, S., & Mach, F. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.015 · Cited by 175
“Indeed, by nhibiting l-mevalonic acid synthesis, statins also prevent he catabolism of several isoprenoid intermediates of the holesterol biosynthetic pathway, such as farnesylpyrophoshate (FPP) and geranylgeranylpyrophosphate (GGPP) [7], hich are known to induce prenylation of numerous cellular roteins.”
BackgroundInfluentialSpecific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
Cox, A. D., Hisaka, M. M., Buss, J. E., & Der, C. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2606 · Cited by 178
Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors
Yokode, M., Hammer, R. E., Ishibashi, S., Brown, M. S., & Goldstein, J. L. (1990) · Science · doi:10.1126/science.2244210 · Cited by 175
Self-citationMachida, K., Tanaka, T., Fujita, K.-I., & Taniguchi, M. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.17.4460-4465.1998 · Cited by 179
Cholesterol Movement in Niemann-Pick Type C Cells and in Cells Treated with Amphiphiles
Lange, Y., Ye, J., Rigney, M., & Steck, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000875200 · Cited by 177
Song, B.-L., & DeBose-Boyd, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605575200 · Cited by 174
Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation
Parameswaran, M., & Tam, P. P. L. (1995) · Developmental Genetics · doi:10.1002/dvg.1020170104 · Cited by 171
REGULATION OF BILE ACID BIOSYNTHESIS
Vlahcevic, Z. R., Pandak, W. M., & Stravitz, R. T. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70041-8 · Cited by 175
Reiss, Y., Brown, M. S., & Goldstein, J. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42709-3 · Cited by 174
Self-citationSchafer, W. R., Trueblood, C. E., Yang, C.-C., Mayer, M. P., Rosenberg, S., Poulter, C. D., Kim, S.-H., & Rine, J. (1990) · Science · doi:10.1126/science.2204115 · Cited by 176
Targeting Rho in Cardiovascular Disease
Laufs, U., & Liao, J. K. (2000) · Circulation Research · doi:10.1161/01.res.87.7.526 · Cited by 171
Laaksonen, R., Jokelainen, K., Laakso, J., Sahi, T., Härkönen, M., Tikkanen, M. J., & Himberg, J.-J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89180-1 · Cited by 171
Correll, C. C., Ng, L., & Edwards, P. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32450-x · Cited by 172
Apoptosis and Cell-Cycle Arrest in Human and Murine Tumor Cells Are Initiated by Isoprenoids
Mo, H., & Elson, C. E. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.4.804 · Cited by 173
“The multivalent regulation of HMG-CoA reductase, elegantly delineated by Goldstein and Brown (1990), consists of three entities, the sterol feedback modulation of transcription, the modulation of the efficiency of HMG-CoA reductase mRNA processing, and the degradation of HMG CoA reductase catalyzed…”
Hanley, K., Jiang, Y., Crumrine, D., Bass, N. M., Appel, R., Elias, P. M., Williams, M. L., & Feingold, K. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119583 · Cited by 171
“To determine whether the effect on barrier development by farnesol, an isoprenoid product of the mevalonate pathway (28), might be FXR-mediated, we also tested the effects of a variety of cholesterol analogs and precursors, as well as other isoprenoids, including the known FXR activator, JH III (23), on the kinetics o…”
BackgroundMovement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex
Naito, T., Ercan, B., Krshnan, L., Triebl, A., Koh, D. H. Z., Wei, F.-Y., Tomizawa, K., Torta, F. T., Wenk, M. R., & Saheki, Y. (2019) · eLife · doi:10.7554/elife.51401 · Cited by 171
“…primarily through receptor-mediated endocytosis of low-density lipoproteins (LDLs) ( Goldstein and Brown, 2015 ) and de novo synthesis in the endoplasmic reticulum (ER) that is controlled by the activation of SREBP transcription factors ( Brown et al., 2018 ; Goldstein and Brown, 1990 ).”
BackgroundMir-33 regulates cell proliferation and cell cycle progression
Cirera-Salinas, D., Pauta, M., Allen, R. M., Salerno, A. G., Ramírez, C. M., Chamorro-Jorganes, A., Wanschel, A. C., Lasuncion, M. A., Morales-Ruiz, M., Suarez, Y., et al. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19421 · Cited by 172
“Intracellular cholesterol is obtained from plasma lipoproteins or synthesized de novo from acetyl-CoA.(1) As an essential component of mammalian cell membranes, cells require cholesterol for proliferation.”
BackgroundA role for geranylgeranylation in interleukin‐1β secretion
Mandey, S. H. L., Kuijk, L. M., Frenkel, J., & Waterham, H. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22194 · Cited by 172
Ehmsen, S., Pedersen, M. H., Wang, G., Terp, M. G., Arslanagic, A., Hood, B. L., Conrads, T. P., Leth-Larsen, R., & Ditzel, H. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.104 · Cited by 173
“In general, cholesterol plays an important role in the structure of membranes and the function of membrane-localized proteins, as well as in cell proliferation and cell survival (Goldstein and Brown, 1990; Liu et al., 2016).”
BackgroundProtein prenylation: more than just glue?
Cox, A. D., & Der, C. J. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90133-w · Cited by 169
Qureshi, A. A., Pearce, B. C., Nor, R. M., Gapor, A., Peterson, D. M., & Elson, C. E. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.2.389 · Cited by 172
Kanazawa, I., Yamaguchi, T., Yano, S., Yamauchi, M., Yamamoto, M., & Sugimoto, T. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-51 · Cited by 168
“AMP kinase is known to have the ability to phosphorylate and inactivate 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, a key regulatory enzyme in the synthesis of cholesterol and other isoprenoid compounds [35].”
Yeganeh, B., Wiechec, E., Ande, S. R., Sharma, P., Moghadam, A. R., Post, M., Freed, D. H., Hashemi, M., Shojaei, S., Zeki, A. A., et al. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.007 · Cited by 169
“HMGCR is the most important and proximal enzyme in this pathway, and serves as the rate-limiting step in cholesterol biosynthesis (Goldstein & Brown, 1984, 1990).”
BackgroundInfluentialSassano, A., & Platanias, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.036 · Cited by 168
“[11] J.”
BackgroundSimvastatin Inhibits Inflammatory Properties of Staphylococcus aureus α-Toxin
Pruefer, D., Makowski, J., Schnell, M., Buerke, U., Dahm, M., Oelert, H., Sibelius, U., Grandel, U., Grimminger, F., Seeger, W., et al. (2002) · Circulation · doi:10.1161/01.cir.0000034048.38910.91 · Cited by 170
Ness, G. C., & Chambers, C. M. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22359.x · Cited by 169
“Sterols were shown to regulate at the level of transcription whereas nonsterols exerted regulation on translation of the mRNA (10).”
BackgroundMethodInfluentialMaintaining cholesterol homeostasis: Sterol regulatory element-binding proteins
Weber, L. W. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i21.3081 · Cited by 172
“At this point in time the so-called statins, drugs which block HMGCoA reductase, another target of SREBPmediated gene expression, are the most effective way to interrupt this vicious circle [ 4 ].”
BackgroundLovastatin inhibits proliferation of rat mesangial cells.
O'Donnell, M. P., Kasiske, B. L., Kim, Y., Atluru, D., & Keane, W. F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116204 · Cited by 168
Inhibitors of ras farnesyltransferases
Tamanoi, F. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90072-u · Cited by 170
The chemical toolbox for monitoring protein fatty acylation and prenylation
Hannoush, R. N., & Sun, J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.388 · Cited by 167
“and isoprenoid precursors (such as [ 3 H]mevalonic acid”
BackgroundCholesterol and beyond - The role of the mevalonate pathway in cancer biology
Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 164
Clinical Pharmacokinetics of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors
Desager, J.-P., & Horsmans, Y. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631050-00003 · Cited by 167
Statins for infection and sepsis: a systematic review of the clinical evidence.
Falagas, M. E., Makris, G. C., Matthaiou, D. K., & Rafailidis, P. I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn019 · Cited by 166
“They inhibit the synthesis of products of mevalonate pathway such as isoprenoids and geranyl-geranylpyrophosphate.(3) In addition, they modify the intercellular interactions and the cellular chemotaxis of the immune system.”
BackgroundFrenkel, J., Rijkers, G. T., Mandey, S. H. L., Buurman, S. W. M., Houten, S. M., Wanders, R. J. A., Waterham, H. R., & Kuis, W. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10550 · Cited by 171
Statins: Effective antiatherosclerotic therapy
Blumenthal, R. S. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90033-4 · Cited by 169
Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway
Zhao, Y., Yang, J., Qin, B., Li, Y., Sun, Y., Su, S., & Xian, M. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3199-1 · Cited by 163
“…MVA pathway operates in the eukaryotes (all mammals), archaea, a few eubacteria and the cytosol and mitochondria of plants, and fungi (Bloch 1992; Goldstein and Brown 1990), whereas the MEP pathway is present in eubacteria including cyanobacteria, plant chloroplasts, algae, and apicomplexan…”
BackgroundEfficacy of statins for osteoporosis: a systematic review and meta-analysis
An, T., Hao, J., Sun, S., Li, R., Yang, M., Cheng, G., & Zou, M. (2017) · Osteoporosis International · doi:10.1007/s00198-016-3844-8 · Cited by 162
“Consequently, the FPP and GGPP synthesis are blocked [49], and these negatively regulate osteoblastic differentiation [50].”
BackgroundHe, B., Chen, P., Chen, S. Y., Vancura, K. L., Michaelis, S., & Powers, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11373 · Cited by 168
Cholesterol is required for infection by Semliki Forest virus.
Phalen, T., & Kielian, M. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.4.615 · Cited by 165
“A well-characterized example is that of HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis (Goldstein and Brown, 1990).”
BackgroundControl of cholesterol synthesis through regulated ER-associated degradation of HMG CoA reductase
Jo, Y., & DeBose-Boyd, R. A. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.485605 · Cited by 164
Sato, R., Goldstein, J. L., & Brown, M. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9261 · Cited by 165
Self-citationSterol-regulated Degradation of Insig-1 Mediated by the Membrane-bound Ubiquitin Ligase gp78
Lee, J. N., Song, B., DeBose-Boyd, R. A., & Ye, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608999200 · Cited by 170
Duncan, R. E., Lau, D., El-Sohemy, A., & Archer, M. C. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.06.022 · Cited by 163
Dimitroulakos, J., Ye, L. Y., Benzaquen, M., Moore, M. J., Kamel‐Reid, S., Freedman, M. H., Yeger, H., & Penn, L. Z. (2001) · PubMed · Cited by 164
Rogers, M. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0024-1 · Cited by 164
“These isoprenoid lipids are the building blocks for the production of a variety of metabolites, such as dolichol and ubiquinone [68], but”
BackgroundThe variability of terpenes in conifers under developmental and environmental stimuli
Kopaczyk, J. M., Warguła, J., & Jelonek, T. (2020) · Environmental and Experimental Botany · doi:10.1016/j.envexpbot.2020.104197 · Cited by 158
Clinical Pharmacokinetics of Fluvastatin
Scripture, C. D., & Pieper, J. A. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140040-00003 · Cited by 163
Evidence of a Role for LytB in the Nonmevalonate Pathway of Isoprenoid Biosynthesis
Cunningham, F. X., Lafond, T. P., & Gantt, E. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.20.5841-5848.2000 · Cited by 163
“Recent evidence (1, 5, 14, 33, 38) indicates that, in contrast to the MVA pathway, the DOXP pathway branches and separately produces DMAPP and IPP.”
BackgroundInfluentialBrain cholesterol in normal and pathological aging
Martin, M., Dotti, C. G., & Ledesma, M. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.011 · Cited by 162
Human cholesterol metabolism and therapeutic molecules
Charlton‐Menys, V., & Durrington, P. N. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2006.035147 · Cited by 164
“3-Hydroxy-3-methyl-glutaryl-CoA reductase is subject to both short-term and long-term control (Goldstein & Brown, 1990).”
BackgroundSqualene, Olive Oil, and Cancer Risk: Review and Hypothesis
NEWMARK, H. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08735.x · Cited by 163
Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
Gronich, N., & Rennert, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.169 · Cited by 161
EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Lo, H. (2010) · Current Molecular Pharmacology · doi:10.2174/1874-470211003010037 · Cited by 174
Heme, iron, and the mitochondrial decay of ageing
Atamna, H. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.02.002 · Cited by 161
Rodrigues Goulart, H., Kimura, E. A., Peres, V. J., Couto, A. S., Aquino Duarte, F. A., & Katzin, A. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2502-2509.2004 · Cited by 162
“In contrast, in humans, isoprenoids are synthesized via the mevalonate pathway (18).”
BackgroundKim, Y.-J., Lee, O. R., Oh, J. Y., Jang, M.-G., & Yang, D.-C. (2014) · Plant Physiology · doi:10.1104/pp.113.222596 · Cited by 162
“HMGR is known as a rate-limiting enzyme of the MVA isoprene pathway in plants (Bach and Lichtenthaler, 1982) and mammals (Goldstein and Brown, 1990).”
Background
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- Nature
- Published
- 1990-02
- Volume
- 343
- Issue
- 6257
- Pages
- 425-430
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2071124826
- Cited by
- 5,394
- References
- 84
- Citations by year
- 2026: 78 · 2025: 101 · 2024: 104 · 2023: 123 · 2022: 143 · 2021: 145 · 2020: 152 · 2019: 147 · 2018: 138 · 2017: 126 · 2016: 146 · 2015: 189 · 2014: 201 · 2013: 180 · 2012: 161
- FWCI
- 33.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- mevalonate pathway, terpenoids, feedback regulation, LDL receptor, cholesterol biosynthesis, growth regulation, cancer therapy, heart disease
- MeSH terms
- Animals, Cell Division, Cholesterol, Farnesol, Gene Expression Regulation, Humans, Hydroxymethylglutaryl CoA Reductases, Hydroxymethylglutaryl-CoA Synthase, Mevalonic Acid, Receptors, LDL, Sterols, Transcription, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.